Links from MedGen
Items: 8
| Gene(s) | Protein change | Condition(s) | Clinical significance (Last reviewed) | Review status |
---|
| - GRCh37:
- Chr5:86628399
- GRCh38:
- Chr5:87332582
| CCNH, RASA1 | Y256*, Y79* | Angioosteohypertrophic syndrome | Pathogenic (Jun 6, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr5:86627168
- GRCh38:
- Chr5:87331351
| CCNH, RASA1 | W181*, W4* | Angioosteohypertrophic syndrome | Pathogenic (Jun 6, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr5:86670700-86670701
- GRCh38:
- Chr5:87374883-87374884
| CCNH, RASA1 | K484fs, K661fs | Angioosteohypertrophic syndrome | Pathogenic (Jun 6, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr3:178948044
- GRCh38:
- Chr3:179230256
| PIK3CA | D939G | Megalencephaly-capillary malformation-polymicrogyria syndrome, Segmental undergrowth associated with mainly venous malformation with capillary component, See cases
| Pathogenic/Likely pathogenic (Dec 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178922324
- GRCh38:
- Chr3:179204536
| PIK3CA | E365K | Megalencephaly-capillary malformation-polymicrogyria syndrome, PIK3CA-related condition, Cowden syndrome, Angioosteohypertrophic syndrome, not provided | Pathogenic (Feb 2, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178917478
- GRCh38:
- Chr3:179199690
| PIK3CA | G118D | Cowden syndrome, Angioosteohypertrophic syndrome, not provided
| Pathogenic (Jun 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:80412493
- GRCh38:
- Chr9:77797577
| GNAQ | R183Q | Familial multiple nevi flammei, Capillary malformation, Sturge-Weber syndrome, Angioosteohypertrophic syndrome, not provided, Segmental undergrowth associated with capillary malformation, Hemangiomatosis | Pathogenic/Likely pathogenic (Oct 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:178947865
- GRCh38:
- Chr3:179230077
| PIK3CA | G914R | Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes | Pathogenic (Feb 12, 2022) | reviewed by expert panel FDA Recognized Database |